Shi, Jiaqi http://orcid.org/0000-0003-4037-0711
Wu, Wei http://orcid.org/0000-0002-3024-380X
Chen, Dong http://orcid.org/0000-0003-3892-9248
Liao, Ziyan
Sheng, Tao
Wang, Yanfang
Yao, Yuejun
Wu, Qing
Liu, Feng
Zhou, Ruyi
Zhu, Chaojie http://orcid.org/0000-0002-9375-6725
Shen, Xinyuan
Mao, Zhengwei http://orcid.org/0000-0001-7990-2856
Ding, Yuan
Wang, Weilin
Dotti, Gianpietro http://orcid.org/0000-0002-2639-8526
Sun, Jie http://orcid.org/0000-0002-5642-0560
Liang, Xiao
Fang, Weijia http://orcid.org/0000-0001-9849-347X
Zhao, Peng http://orcid.org/0000-0002-5479-899X
Li, Hongjun http://orcid.org/0000-0002-1765-8445
Gu, Zhen http://orcid.org/0000-0003-2947-4456
Article History
Received: 17 November 2022
Accepted: 31 January 2024
First Online: 6 March 2024
Competing interests
: Related patents have been applied for by Z.G., H.L., J. Shi and W. Wu (patent applicant: Zhejiang University; name of inventors: Zhen Gu, Hongjun Li, Jiaqi Shi, Wei Wu; application number: 2022113666477; status of application: substantive examination; specific aspect of paper covered in patent application: preparation of CAR T cell-loaded lyophilizing lymph nodes and its anti-tumour application). Z.G. is the cofounder of Zenomics Inc., ZCapsule Inc. and <i>ยต</i>Zen Inc. The other authors declare no competing interests.